Table 3: Group comparison of disorder classification and ambulatory treatment by mortality.

 

Total

Did Not Survive

Survived

P-value

Started of symptoms until register

7.6 ± 6.6

7.25 ± 5.47

7.95 ± 7.24

< 0.001

Classification disorder

   

< 0.001

Influeza type disease

3495 (47.3)

649 (22.2)

2846 (63.6)

 

Serious Acute Respiratory Infection

3899 (52.7)

2268 (77.8)

1631 (36.4)

 

Ambulatory treatment

     

Antipiretics

3292 (44.5)

1142 (39.7)

2150 (48.3)

< 0.001

Antibiotics

1746 (23.6)

739 (68.0)

1007 (31.2)

< 0.001

Antiviral

1098 (14.8)

586 (21.7)

512 (11.9)

< 0.001

Type of antiviral

 

 

 

0.004

Aciclovir

2 (0.02)

0

2 (0.2)

 

Amantadina

18 (0.2)

5 (0.9)

13 (2.6)

 

Lopinavir/Ritonavir

28 (0.4)

7 (1.2)

21 (4.1)

 

Oseltamivir

1038 (14.0)

570 (97.4)

468 (92.3)

 

Rimantadina

4 (0.1)

2 (0.3)

2 (0.4)

 

Zavamivir

2 (0.02)

1 (0.2)

1 (0.2)